|
|
|
|
Founder of Baker Bros. Advisors LP, Felix James Baker presently is Limited Partner at this company and Co-Managing Partner at Baker Bros. Advisors GP LLC (a subsidiary of Baker Bros. Advisors LP).
He is also on the board of Alexion Pharmaceuticals, Inc., Seattle Genetics, Inc., Kiniksa Pharmaceuticals Ltd. and Kodiak Sciences, Inc. and Manager of Fbb2 LLC, Co-Managing Partner at Baker Bros. Advisors GP LLC and Partner at FBB Associates.
In the past he held the position of Chairman at Synageva BioPharma Corp. and Owner at VaxGen, Inc.
Dr. Baker received a doctorate and an undergraduate degree from Stanford University.
|
| Postes et responsabilités de Felix James Baker | |
|
| Nom | Titre |
Depuis |
 Alexion Pharmaceuticals, Inc.
(Produits pharmaceutiques) |
Independent Director |
- | Seattle Genetics, Inc.
(Recherche biotechnologique et médicale) |
Lead Independent Director |
2005 | Kodiak Sciences Inc.
(Recherche biotechnologique et médicale) |
Director |
2015 | Kiniksa Pharmaceuticals, Ltd.
(Recherche biotechnologique et médicale) |
Lead Independent Director |
2015 | | Fbb2 LLC |
Manager |
- | | Baker Bros. Advisors GP LLC |
Co-Managing Partner |
- | | FBB Associates |
Partner |
- | | Baker Bros. Advisors LP |
Limited Partner |
2000 |
|
| Participations de Felix James Baker | |
|
| Nom | Actions | % | Valorisation |
Incyte Corporation (INCY)
(Recherche biotechnologique et médicale) | 281 190 | 0,13% | 24 553 511 USD |
Seattle Genetics, Inc. (SGEN)
(Recherche biotechnologique et médicale) | 107 511 | 0,063% | 12 284 207 USD |
Alexion Pharmaceuticals (ALXN)
(Produits pharmaceutiques) | 65 810 | 0,030% | 7 117 352 USD |
 BeiGene, Ltd. (49B)
(Recherche biotechnologique et médicale) | 311 143 | 0,031% | 3 993 209 USD |
BioCryst Pharmaceuticals, Inc. (BCRX)
(Recherche biotechnologique et médicale) | 23 459 | 0,015% | 80 934 USD |
Idera Pharmaceuticals, Inc. (IDRA)
(Recherche biotechnologique et médicale) | 21 929 | 0,076% | 39 911 USD |
Aquinox Pharmaceuticals Inc (NLTX)
(Recherche biotechnologique et médicale) | 2 260 | 0,0046% | 27 843 USD |
Mirati Therapeutics, Inc. (MRTX)
(Recherche biotechnologique et médicale) | 137 | 0,0003% | 17 654 USD |
|
| Felix James Baker: Réseau personnel | |
|
|
© 2020 People and Ownership : 
|
|
|
| Felix James Baker : Connexions | |
|
|
|
United States
United Kingdom
Canada
Deutschland
Schweiz (DE)
bourse
